Toggle Main Menu Toggle Search

Open Access padlockePrints

Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial

Lookup NU author(s): Dr Deborah Stocken

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background/Aims: The influence of type of surgery and occurrence of post-operative complications on survival following adjuvant therapy for pancreatic cancer are uncertain. Methods: Cox proportional hazard modelling was used to investigate the influence of type of surgery and the presence of complications on survival in conjunction with clinico-pathological variables in the 550 patients of the ESPAC-1 adjuvant randomized controlled trial. Results: Standard Kausch-Whipple (KW) was performed in 282 (54%) patients, 186 (35%) had a pylorus-preserving (PP) KW, 39 (7%) had a distal pancreatectomy and 21 (4%) had a total pancreatectomy. Post-operative complications were reported in 140 (27%) patients. PP-KW patients survived longer with a median (95% CI) survival of 19.9 (17.3, 23.1) months compared to 14.8 (13.0, 16.7) for KW patients (=χ2LR = 15.1, p < 0.001). KW patients were more likely however to have R1 margins (67 (24%) vs. 29 (16%), =χ2 = 4.59, p = 0.032), poorly differentiated tumours (70 (26%) vs. 19 (10%), =χ2 = 18.65, p < 0.001) and positive lymph nodes (165 (60%) vs. 81 (44%), =χ2 = 11.32, p < 0.001). Post-operative complications did not significantly affect survival. Independent prognostic factors were tumour grade, nodal status and tumour size but not type of surgery or post-operative complications. There was a survival benefit for chemotherapy irrespective of the type of surgery or post-operative complications. Conclusions: The KW and PP-KW procedures did not significantly influence the hazard of death in the presence of tumour staging, demonstrating that ESPAC-1 surgeons showed good judgement in their choice of operation. Post-operative complications did not adversely affect the survival benefit from adjuvant chemotherapy.


Publication metadata

Author(s): Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H, Dervenis C, Dunn JA, Deakin M, Carter R, Ghaneh P, Neoptolemos JP, Büchler MW, for the members of the European Study Group for Pancreatic Cancer (ESPAC)

Publication type: Article

Publication status: Published

Journal: Digestive Surgery

Year: 2005

Volume: 22

Issue: 5

Pages: 353-363

Print publication date: 01/01/2005

ISSN (print): 0253-4886

ISSN (electronic): 1421-9883

Publisher: S. Karger AG

URL: http://dx.doi.org/10.1159/000089771

DOI: 10.1159/000089771


Altmetrics

Altmetrics provided by Altmetric


Share